Zacks Investment Management Pacific Biosciences Of California, Inc. Transaction History
Zacks Investment Management
- $8.87 Billion
- Q2 2024
A detailed history of Zacks Investment Management transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 26,479 shares of PACB stock, worth $45,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,479Holding current value
$45,014% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
258Shares Held
234MCall Options Held
1.02MPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$56.5 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$44.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$40.1 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$39.8 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$28.5 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $382M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...